Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2018 - 2026)
Collegium Pharmaceutical (COLL) posted Amortizatization of Intangibles of $45000.0 for Q2 2026, down 74.72% on a QoQ basis from $178000.0 in Q1 2026, and down 82.95% year-over-year from $264000.0 in Q2 2025.
Analysis
Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Collegium Pharmaceutical has reported Amortizatization of Intangibles for 5 years, with the latest figure at $45000.0 in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 82.95% year-over-year to $45000.0 in Q2 2026; TTM through Jun 2026 was $707000.0, a 52.17% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 47.14% from the prior year.
- Amortizatization of Intangibles was $45000.0 for Q2 2026 at Collegium Pharmaceutical, down from $178000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $723000.0 in Q2 2024, with the low at $45000.0 in Q2 2026.
- Average Amortizatization of Intangibles over 4 years is $371666.7, with a median of $350000.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2026: Amortizatization of Intangibles declined 9.67% in 2024, then sank 82.95% in 2026.
- Over 4 years, Amortizatization of Intangibles stood at $568000.0 in 2023, then tumbled by 33.8% to $376000.0 in 2024, then sank by 32.45% to $254000.0 in 2025, then plunged by 82.28% to $45000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $45000.0 (Q2 2026), $178000.0 (Q1 2026), and $254000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 984.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 4.33 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | 45,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45,000.00 |
| Mar 31, 2026 | 178,000.00 |
| Dec 31, 2025 | 254,000.00 |
| Sep 30, 2025 | 230,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 324,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Sep 30, 2024 | 514,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Mar 31, 2024 | 415,000.00 |
| Dec 31, 2023 | 568,000.00 |
| Sep 30, 2023 | 569,000.00 |
| Mar 31, 2018 | 29.53 Mn |